title: Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement?
authors.affiliation: Department of Internal Medicine University of Palermo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Malta
authors.forename: M
authors.initials: M
authors.lastname: Affronti
authors.forename: S
authors.initials: S
authors.lastname: Di Rosa
authors.forename: M
authors.initials: M
authors.lastname: Scardavi
authors.forename: M
authors.initials: M
authors.lastname: Renda
authors.forename: G
authors.initials: G
authors.lastname: Trifiró
authors.forename: S
authors.initials: S
authors.lastname: Peralta
authors.forename: F
authors.initials: F
authors.lastname: Savalli
authors.forename: G B
authors.initials: GB
authors.lastname: Rini
mesh_terms: D015746:Abdominal Pain / Q000139:chemically induced*; D000293:Adolescent; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D007238:Infarction / Q000139:chemically induced; D008297:Male; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects*; D013154:Spleen / Q000098:blood supply; D013163:Splenomegaly / Q000139:chemically induced; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate